Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Rheumatology

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12233883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sjögren’s Syndrome or Autoimmune Epithelitis?

  2007cited by this paper
• Aberrant High Expression of B Lymphocyte Chemokine (Blc/Cxcl13) by C11b+Cd11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells towards Blc

  2001cited by this paper
• CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

  2001cited by this paper
• Interleukin-18 regulates both Th1 and Th2 responses.

  2001cited by this paper
• Treatment with anti‐CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up‐regulated Th2 response

  2000cited by this paper
• Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome.

  1999cited by this paper
• Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren's syndrome.

  1998cited by this paper
• In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.

  1997cited by this paper
• Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts.

  1997cited by this paper
• A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome.

  1996cited by this paper
• Functional diversity of helper T lymphocytes

  1996cited by this paper
• Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response

  1995cited by this paper
• Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

  1995cited by this paper
• Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

  1995cited by this paper
• Interferon-gamma and epithelial cell activation in Sjögren's syndrome.

  1995cited by this paper
• Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

  1995cited by this paper
• B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

  1995cited by this paper
• Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

  1995cited by this paper
• Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.

  1995cited by this paper
• T-cell receptor V alpha and V beta gene use by infiltrating T cells in labial glands of patients with Sjögren's syndrome.

  1995cited by this paper
• Expression of the Co-stimulator Molecule B7–1 in Pancreatic β-Cells Accelerates Diabetes in the NOD Mouse

  1995cited by this paper
• A model to study viral and cytokine involvement in Sjögren's syndrome.

  1994cited by this paper
• Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease.

  1994cited by this paper
• Treatment of murine lupus with CTLA4Ig.

  1994cited by this paper
• Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.

  1994cited by this paper
• Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome

  1993cited by this paper
• Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

  1993cited by this paper
• Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.

  1993cited by this paper
• Requirements for CD28-dependent T cell-mediated cytotoxicity.

  1993cited by this paper
• CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

  1992cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

  1990cited by this paper
• Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1

  1989cited by this paper
• Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

  1988cited by this paper
• Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti‐CD28 and anti‐CD2 monoclonal antibodies

  1988cited by this paper
• B7, a B-cell-restricted antigen that identifies preactivated B cells.

  1987cited by this paper
• Organ‐Specific Autoimmunity: A 1986 Overview

  1986cited by this paper
• Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome.

  1986cited by this paper
• Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

  1986cited by this paper
• Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome.

  1985cited by this paper
• Labial salivary gland biopsy in Sjögren's disease

  1968cited by this paper

• Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies

  2026cites this paper
• Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment

  2025cites this paper
• The ‘target tissues’ as orchestrators of autoimmune responses: the paradigm of Sjögren’s syndrome

  2025cites this paper
• m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren’s disease

  2024cites this paper
• Human erythroid progenitors express antigen presentation machinery

  2024cites this paper
• Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sjögren’s Syndrome

  2024cites this paper
• Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

  2024cites this paper
• TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes.

  2023cites this paper
• Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials

  2022cites this paper
• Sjögren’s Syndrome: A Brief Review to Newly Qualified Dentists

  2022cites this paper
• Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome

  2022cites this paper
• Epitope Mapping of Pathogenic Autoantigens on Sjögren’s Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques

  2022cites this paper
• SHED-derived exosomes ameliorate hyposalivation caused by Sjögren's syndrome via Akt/GSK-3β/Slug-mediated ZO-1 expression

  2022cites this paper
• Mucosal immunology of the ocular surface

  2022cites this paper
• Why Should We Consider Potential Roles of Oral Bacteria in the Pathogenesis of Sjögren Syndrome?

  2022cites this paper
• The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjögren’s Syndrome

  2021influential citation
• Salivary dysbiosis in Sjögren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells

  2021cites this paper
• Advances in Pathogenesis of Sjögren's Syndrome

  2021cites this paper
• Management of Sjögren's Syndrome: Present Issues and Future Perspectives

  2021cites this paper
• Salivary dysbiosis in Sjögren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells

  2021cites this paper
• New frontiers in precision medicine for Sjogren’s syndrome

  2021cites this paper
• Immunobiology of T Cells in Sjögren’s Syndrome

  2020influential citation
• Dysbiotic oral microbiota and infected salivary glands in Sjögren’s syndrome

  2020cites this paper
• B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice

  2020cites this paper
• P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction

  2020cites this paper
• Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes.

  2020cites this paper
• Cell adhesion molecules’ altered profile in benign and malignant salivary gland tumors. The paradigm of beta4-integrin, desmoglein-2, ICAM-1 and CD44s

  2020cites this paper
• Checkpoint inhibition-induced sicca: a type II interferonopathy?

  2020cites this paper
• Contributions of Major Cell Populations to Sjögren’s Syndrome

  2020cites this paper
• Salivary gland epithelial cells from patients with Sjögren’s syndrome induce B-lymphocyte survival and activation

  2020cites this paper
• Rationale for CD40 pathway blockade in autoimmune rheumatic disorders.

  2020cites this paper
• Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond.

  2019cites this paper
• Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment.

  2019cites this paper
• Renal involvement in primary Sjogren’s syndrome: a prospective cohort study

  2018cites this paper
• Gene Expression Profiling of Lacrimal Glands Identifies the Ectopic Expression of MHC II on Glandular Cells as a Presymptomatic Feature in a Mouse Model of Primary Sjögren's Syndrome

  2018cites this paper
• MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain

  2017cites this paper
• P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy

  2017influential citation
• Update on Pathogenesis of Sjogren's Syndrome.

  2017cites this paper
• Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers.

  2016cites this paper
• Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren’s syndrome

  2016cites this paper
• Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs

  2016cites this paper
• Leptin and leptin receptors in salivary glands of primary Sjögren's syndrome.

  2016cites this paper
• Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

  2016cites this paper
• Primary Sjögren’s syndrome: clinical phenotypes, outcome and the development of biomarkers

  2016cites this paper
• Long non-coding RNA expression profile in minor salivary gland of primary Sjögren’s syndrome

  2016cites this paper
• Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation.

  2016cites this paper
• The Role of Immunological Receptors CD74 and CD44 in Association with the Macrophage Migration Inhibitory Factor (MIF) on Human Breast Cancer Derived Cells

  2016cites this paper
• Chemokine (C-X-C Motif) Ligand 1 (CXCL1) Expression in the Minor Salivary Glands of Sjögren's Syndrome Patients

  2016cites this paper
• Chemokine ( CXC Motif ) Ligand 1 ( CXCL 1 ) Expression in the Minor Salivary Glands of Sjögren ’ s Syndrome Patients

  2016cites this paper
• Renal involvement in primary Sjögren syndrome

  2016cites this paper
• Profiling microRNA in Primary Sjögren’s Syndrome: A quantitative and qualitative analysis of an Irish cohort

  2015cites this paper
• Saliva as a potential tool for diagnosis of dry mouth including Sjögren's syndrome.

  2015cites this paper
• Differences of stimulated and unstimulated salivary flow rates in patients with dry mouth

  2015cites this paper
• Development and description of a novel inducible model of salivary gland inflammation in C57BL/6 mice characterised by tertiary lymphoid structures, autoimmunity and exocrine dysfunction

  2015influential citation
• The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review

  2015influential citation
• The complexity of the BAFF forms and their functional implications

  2014cites this paper
• Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome

  2014influential citation
• Immune checkpoint receptors in regulating immune reactivity in rheumatic disease

  2014cites this paper
• Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Faslpr mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2

  2014cites this paper
• Proteasome Defects and Cytokine Signaling in Sjögren’s Syndrome

  2014cites this paper
• Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases.

  2014cites this paper
• Costimulatory Molecules in Rheumatic Diseases Revisited with an Emphasis on Their Roles in Autoimmune Sjögren’s Syndrome

  2013cites this paper
• Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand

  2013cites this paper
• Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and Effects

  2013cites this paper
• Type I interferons in Sjögren's syndrome.

  2013cites this paper
• Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD

  2013cites this paper
• T helper cytokines in dry eye disease.

  2013cites this paper
• Faculté de Médecine Contribution to the diagnosis and pathophysiology of Sjögren’s Syndrome

  2013cites this paper
• Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome

  2012cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome

  2012cites this paper
• Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

  2012cites this paper
• Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndrome.

  2012cites this paper
• Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease.

  2012cites this paper
• Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.

  2012cites this paper
• The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland.

  2012cites this paper
• Primary Sjögren’s syndrome: current pathophysiological, diagnostic and therapeutic advances

  2011cites this paper
• Relative Efficacy of Uptake and Presentation of Mycobacterium bovis BCG Antigens by Type I Mouse Lung Epithelial Cells and Peritoneal Macrophages

  2011cites this paper
• The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis

  2011cites this paper
• Pathogenetic Aspects of Primary Sjögren’s Syndrome

  2011cites this paper
• Gene therapy: Sjögren’s syndrome

  2010cites this paper
• The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome.

  2010cites this paper
• Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

  2010cites this paper
• Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome

  2010cites this paper
• Interferon Type I Driven Immune Activation in Generalized Autoimmune Diseases

  2010cites this paper
• Classification and diagnosis of dry mouth

  2009cites this paper
• Significance of the Tests of Whole Salivary Flow Rate and the moisture measurement of lingual surface in the Diagnoses of Xerostomia

  2009cites this paper
• P2Y2 Nucleotide Receptor Activation Up-regulates Vascular Cell Adhesion Molecular-1 Expression and Enhances Lymphocyte Adherence to a Human Submandibular Gland Cell Line

  2008influential citation
• P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

  2008cites this paper
• CD 40-CD 40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p 50 in cultured salivary gland epithelial cells from patients with Sjögren ’ s syndrome

  2007cites this paper
• CD40-CD40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p50 in cultured salivary gland epithelial cells from patients with Sjögren's syndrome

  2007cites this paper
• SJÖGREN’S SYNDROME WITH LYMPHOMA-DEPENDENT PRODUCTION OF ANTI-RO52 AUTOANTIBODIES

  2007cites this paper
• B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

  2007cites this paper
• T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology

  2007cites this paper
• The Role of Epithelial Cells in the Pathogenesis of Sjögren’s Syndrome

  2007cites this paper
• The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjögren’s syndrome (autoimmune epithelitis)

  2006cites this paper
• B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

  2006cites this paper
• Sjögren's syndrome: why autoimmune epithelitis?

  2006cites this paper
• Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy

  2005cites this paper
• Sjögren's syndrome.

  2005cites this paper